Microdosing LSD is not an effective ADHD treatment

Take small frequent doses from LSD anesthetic anesthetic It does not reduce the symptoms of hyperactivity disorder and attention shortage more than an imaginary drug.

Microoring losses The narcotic drugs include taking them several times a week in small doses enough to not try hallucinations. Although there is Few guides support itThere is a widespread idea that this can enhance luxury, creativity and focus. Some studies have shown that people with Microdose as a method of treatment ADHD Did the symptoms of reporting improve, but these studies were noticeable and relied on self -reported data?

To test the effects of medications on hyperactivity disorder and a lack of attention more, Matthias Lycti At Basel University in Switzerland and his colleagues conducted the first random experience ever governed by the Microd Microd dose for ADHD. They recruited 53 adults who live in the Netherlands or Switzerland, who were diagnosed with hyperactivity disorder, lack of attention, and moderate to severe symptoms. Twenty-seven participants made a dose of 20 micrograms of LSD twice a week-at the upper end of Microdoses, but still about five standard doses-while the rest was granted an imaginary medicine.

Symptoms of hyperactivity disorder and attention lack were evaluated at the beginning of the study and after six weeks using a scale of 54 points, as the highest levels indicated more severe symptoms. On average, the grades decreased by about 7 points in the participants who got LSD and about 9 points in those that give the placebo. This is not a big difference, which indicates that LSD is not better than the imaginary medicine in improving the symptoms of hyperactivity disorder and lack of attention, says Lyceti.

However, the dose may not have been suitable for treating hyperactivity disorder and lack of attention. LSD may also be considered daily to experience a decrease in symptoms, similar to how current ADHD drugs work, he says Connor Murray At the University of California, Los Angeles.

“We still need to know if the sharp dose – meaning while the drug is in your body – does this have any decrease in symptoms?” Murray says. “This is a kind of first step. And if it doesn’t happen, do not even have to ask whether there is any permanent change.”